Geneoscopy
JP Morgan Healthcare Conference, Day 4: Standard BioTools, Geneoscopy, OraSure Technologies
Highlights from the fourth day included Geneoscopy's plans to increase access to its ColoSense colorectal cancer screening test through its partnership with Labcorp.
Geneoscopy Closes $105M Series C Financing Led by Bio-Rad to Market CRC Screening Test
Geneoscopy will also work with Labcorp to more broadly disseminate its stool-based test, which uses Bio-Rad's Droplet Digital PCR technology.
Geneoscopy Gets Lab Permit From New York State Department of Health
With the New York lab permit, the St. Louis-based company can now offer its ColoSense colon cancer screening test throughout the US.
US Patent Trial and Appeal Board to Review Exact Sciences Patent Contested by Geneoscopy
The appeal board determined that Geneoscopy has a "reasonable likelihood" of proving at least one claim the company had alleged in requesting the review.
Geneoscopy Countersues Exact Sciences Over Patent Central to Cologuard
Geneoscopy alleges that Exact Sciences has misappropriated its trade secrets, breached contract, and engaged in unfair competition.